TDCS to Improve Motivation and Memory in Elderly (TIME)
Noninvasive Brain Stimulation as a Tool to Study the Role of Motivation in Age-related Cognitive Abilities
2 other identifiers
interventional
72
1 country
1
Brief Summary
Fundamental advancements in understanding successful aging are limited by the lack of causal, rather than just correlational methods to connect age-related changes in memory ability to changes in brain structure and function. In this study, non-invasive electric brain stimulation will be used as a tool to create causal links between successful memory function in aging and brain structures associated with motivation. Recently, it was shown that a group of elderly, dubbed "superagers", are indistinguishable from young adults in memory performance and the structure of cortical limbic regions. A key superaging region is mid-cingulate cortex (MCC), a brain structure associated with motivation and tenacity. The MCC is a hub region that synchronizes information flow between three core brain networks. The goal of the research is to explore the contribution of motivation to memory performance by modulating MCC connectivity with transcranial direct current stimulation (tDCS) to provide the first causal evidence that experimentally induced motivation can improve memory performance. Since MCC has not been stimulated with tDCS before, we will test three different stimulation protocols and compare against a placebo. The stimulation protocols were computationally optimized for this project. The primary aim is to find the stimulation protocol most successful at improving memory performance. In order to elucidate the mechanisms behind these changes, effects of stimulation on motivation and network connectivity will be investigated. If indeed memory can be improved by increasing motivation and effort via stimulating MCC, this study will generate new insights into the motivational mechanisms of successful aging.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 22, 2020
CompletedFirst Submitted
Initial submission to the registry
February 10, 2020
CompletedFirst Posted
Study publicly available on registry
February 13, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2020
CompletedFebruary 13, 2020
February 1, 2020
7 months
February 10, 2020
February 11, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in "Feeling of difficulty" from baseline
Self-reports of difficulty will be queried during a memory task. Feeling of difficulty asks "How easy or difficult do you think the task will be (did you find the task)?" Answer is reported on a 7 point-scale.
1 week
Change in "Estimates of effort" from baseline
Self-reports of effort will be queried during a memory task. Estimates of Effort asks "How much effort do you think it will take you (did it take you) to complete the task?" Answer is reported on a 7 point-scale.
1 week
Change in "NASA Task Load Index" from baseline
NASA Task Load Index will be queried during a memory task. It includes self-report scales that provide state markers of cognitive effort.
1 week
Change in "Time to complete unsolvable anagrams" from baseline
Time in seconds participants spend on unsolvable anagram task before quitting.
1 week
Secondary Outcomes (3)
Change in "Memory recognition discriminability (d')" from baseline
1 week
Change in "Intrinsic functional connectivity strength" from baseline
1 week
Change in "California Verbal Learning Test" score from baseline
1 week
Study Arms (4)
Direct tDCS
EXPERIMENTALTranscranial direct current stimulation (tDCS) was computationally optimized to target mid-cingulate cortex directly.
Indirect tDCS
EXPERIMENTALTranscranial direct current stimulation (tDCS) was computationally optimized to target the middle frontal gyrus, a brain area connected to mid-cingulate cortex.
Personalized tDCS
EXPERIMENTALTranscranial direct current stimulation (tDCS) will be individually optimized to simultaneously stimulate key nodes connected to mid-cingulate cortex, including anterior insula, MFG and supramarginal gyrus.
Sham tDCS
SHAM COMPARATORPlacebo transcranial direct current stimulation (tDCS) will be applied.
Interventions
Transcranial direct current stimulation (tDCS) will be applied. Stimulation amplitude is 2 mA. Stimulation duration is 20 minutes. The configuration used is two electrodes at AFz and CPz of the 10-10 electrode system.
Transcranial direct current stimulation (tDCS) will be applied. Stimulation amplitude is 2 mA. Stimulation duration is 20 minutes. The configuration used is two electrodes at AF3 and AF4 of the 10-10 electrode system.
Transcranial direct current stimulation (tDCS) will be applied. Stimulation amplitude is 2 mA. Stimulation duration is 20 minutes. The configuration used will be optimized to stimulate key nodes connected to MCC, including anterior insula, MFG and supramarginal gyrus, and designed using an individual head model that will be combined with each subject's measured connectivity map. The number of electrodes will be minimally 2 and maximally 32.
Transcranial direct current stimulation (tDCS) will be applied. Stimulation amplitude is 2 mA. Stimulation duration is 20 minutes. Placebo stimulation will be applied by ramping the current up and immediately down over 30 seconds. The configuration used is two electrodes at AF3 and AF4 of the 10-10 electrode system.
Eligibility Criteria
You may qualify if:
- between the ages of 65 and 80
- normal or corrected to normal vision
- fluent in speaking, reading and understanding English
- right-handed
You may not qualify if:
- any metal implants that may cause harm through MRI scanning
- other metals that may interfere with obtaining MRI signals
- claustrophobic
- pregnancy
- history of neurological or psychiatric illnesses
- history of fainting, seizures or epilepsy
- history of migraines
- history of drug abuse
- learning disability
- intracranial lesion
- any prescription or regular medication except for birth control
- any uncontrolled medical condition
- skin disease or damage on scalp
- hair style or head dress that prevents electrode contact with the scalp
- any condition affecting agility of hands (e.g. acute or chronic tenosynovitis, active joint deformity of arthritic origin)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northeastern Universitylead
- Massachusetts General Hospitalcollaborator
- National Institute on Aging (NIA)collaborator
Study Sites (1)
Northeastern University
Boston, Massachusetts, 02115, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sumientra M Rampersad, PhD
Northeastern University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant Professor
Study Record Dates
First Submitted
February 10, 2020
First Posted
February 13, 2020
Study Start
January 22, 2020
Primary Completion
September 1, 2020
Study Completion
September 1, 2020
Last Updated
February 13, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Data will be made available within 6 months after publication.
- Access Criteria
- Data will be freely available on our lab website.
De-identified connectivity maps and motivation and memory task data will be made available via our lab website.